Leading pharmaceutical technology unifies quality processes for greater efficiency, collaboration and compliance

BARCELONA, Spain, Sept. 14, 2023 /PRNewswire/ — Veeva Systems (NYSE: VEEV) today announced that LTS LOHMANN Therapie-Systeme AG (“LTS”), a leading pharmaceutical technology company, is partnering with Veeva MedTech to advance in its quality operations. LTS will use Veeva Vault QMS to improve process control and visibility, align global production sites, and increase audit readiness.

“As we continue to grow, we need a modern, scalable and easy-to-use quality management tool to harmonize and advance our quality processes across the organization,” said Dr. Heike Barnikow-Bock, corporate vice president of operations, projects. quality and consulting. LTS. “With Veeva Vault QMS, we will strengthen GxP monitoring and compliance while aligning with our customers’ quality requirements.”

“Veeva’s open collaboration and flexibility in meeting our needs make them the perfect partner,” said Christian Langer, corporate senior vice president of global quality at LTS. “The team’s extensive experience and focus on execution made it possible to complete this project in such a short time.”

Headquartered in Germany with four sites in North America, Europe and Asia, LTS develops and manufactures drug delivery systems, such as transdermal patches, oral thin films and wearable drug delivery devices. Vault QMS will help LTS manage and track quality processes such as deviations, complaints, laboratory incidents, corrective and preventive actions, and change control. By improving its quality management processes, LTS can provide greater value to its partners and drive better patient outcomes, which aligns with LTS’ purpose: “WE CARE. WE CREATE. WE DELIVER.”

“Veeva Vault QMS helps companies like LTS simplify quality processes for greater efficiency while ensuring continuous inspection readiness,” said Patrik Brehm, director of quality strategy for Veeva MedTech in Europe. “Veeva is proud to partner with the team to help optimize their quality operations.”

Veeva MedTech offers unified and connected cloud software solutions to help deliver medical devices and diagnostics to patients who need them. Includes Veeva Vault products in R&D and commercial to help accelerate the total product development lifecycle for medical technology companies.

Vault QMS is part of the Vault Quality Suite, which brings together quality systems and processes on a single cloud platform to enable efficient quality management.

About Veeva Systems

Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence and customer success, Veeva serves more than 1,000 customers, from the world’s largest biopharmaceutical companies to emerging biotechnology companies. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com/eu

Veeva Forward-Looking Statements

This release contains forward-looking statements about Veeva’s products and services and the expected results or benefits from the use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we undertake no obligation to update such statements. There are numerous risks that have the potential to adversely affect our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended July 31, 2023, which can be found here (a summary of the risks that may affect our business can be found on pages 38 and 39) and in our subsequent filings with the SEC, which can be accessed at sec.gov.

Contact:

Jeremy WhittakerVeeva Systems 49-695-095-5486jeremy.whittaker@veeva.com

Logo – https://mma.prnewswire.com/media/1488285…

View original content: https://www.prnewswire.com/news-releases/lts-avanza-en-la-supervision-de-la-calidad-con-veeva-vault-qms-301927873.html